Kidney disease drug developer Sorbent Therapeutics raises $21M - MedCity News PDF Print
MedCity NewsSorbent Therapeutics Inc. has raised a $21 million Series B round to fund Phase 2 clinical trials of a nonabsorbed polymer-based drug for end-stage renal

... read more

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.